Lab21 appoints group director
Of quality, regulatory affairs and operations excellence
Dr Logue worked for almost two decades in divisions of Abbott Laboratories. He was most recently division vice president World Wide Manufacturing for Abbott Diabetes Care, moving from division vice president European Operations. Prior to this he was operations director for Abbott Diagnostics Division Ireland, and director of Quality & Regulatory and marketing manager for Abbott Diagnostics Division in Germany.
Dr Logue said: ‘Lab21 has achieved remarkable progress within the past 4 years, growing five times in size. I am looking forward to contributing to its future success.’
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Analysis
Semaglutide patent cliff: pharma industry braces for impact
With the weight-loss industry shifting from a monopoly held by innovators to a high-volume, competitive generic market, the pharma manufacturing sector is gearing up for a "generic wave" with investments into large-scale protein synthesis and facilities for injectables